Hypophosphatasia
Hypophosphatasia is a rare inherited metabolic disorder that affects the development and mineralisation of bones and teeth. It is caused by low activity of an enzyme called tissue-nonspecific alkaline phosphatase (ALP), which can lead to abnormal accumulation of substances that interfere with normal bone mineralisation.
The condition can vary widely in severity. It may appear during infancy, childhood, or adulthood, and symptoms depend on the age of onset and the extent of bone and dental involvement.
Quick Facts
Condition | Hypophosphatasia |
Type | Rare inherited metabolic disorder |
Affects | Bones, teeth and musculoskeletal system |
Commonly associated with | Low alkaline phosphatase activity and impaired bone mineralisation |
Symptoms | Bone weakness, fractures, muscle pain, premature loss of teeth and difficulty walking |
Treatment | Enzyme replacement therapy and supportive care |
Specialists | Endocrinologists, metabolic specialists, paediatricians and other specialists |
How Does Hypophosphatasia Affect the Body?
Hypophosphatasia is usually caused by changes in the ALPL gene, which provides instructions for producing tissue-nonspecific alkaline phosphatase. Reduced activity of this enzyme interferes with the normal mineralisation of bones and teeth.
Symptoms depend on the form of the condition. Infants and children with more severe forms may develop weak or poorly mineralised bones, poor growth, muscle weakness, or early loss of primary teeth. Adults may experience bone pain, fractures, muscle pain, or difficulty walking.
Treatment is based on the severity and form of the condition. Enzyme replacement therapy may be used in eligible patients, while supportive care can help manage bone, dental, and mobility-related problems. Regular monitoring helps doctors assess bone health and treatment response.
FAQs
Q1. How can I order Hypophosphatasia medicines from MrMed?
Search for your prescribed medicine on MrMed and provide the required prescription details when placing an order.
Q2. Can Hypophosphatasia medicines interact with other medicines or supplements?
Yes. Hypophosphatasia medicines may interact with prescription medicines, over-the-counter medicines, and supplements. Tell your doctor about everything you take before starting treatment.
Q3. What are the common side effects of Hypophosphatasia medicines?
Side effects depend on the medicine being used. Some may include:
Injection-site reactions
Headache
Nausea
Fever
Irritability
Talk to your doctor if you have severe or persistent side effects.
Q4. What precautions should I take while using Hypophosphatasia medicines?
Follow the prescribed dose and schedule. You should also:
Tell your doctor about all the medicines and supplements you take.
Inform them about other health conditions.
Attend recommended bone, dental, and laboratory assessments.
Follow the administration and storage instructions provided for your medicine.
Do not change the dose or stop treatment without medical advice.
Q5. How are Hypophosphatasia medicines safely delivered?
MrMed follows the required storage, handling, packing, and transportation practices for medicines. Medicines with specific storage requirements are handled accordingly during delivery.
Q6. What are the symptoms of Hypophosphatasia?
Symptoms vary depending on the age of onset and severity. They may include:
Weak or poorly mineralised bones
Bone pain
Fractures
Muscle weakness or pain
Difficulty walking
Premature loss of primary teeth
Poor growth in children
Severe forms may cause significant complications involving the bones, chest, or respiratory system.
Q7. What causes Hypophosphatasia?
Hypophosphatasia is caused by changes in the ALPL gene, which reduce the activity of tissue-nonspecific alkaline phosphatase. This interferes with normal mineralisation of bones and teeth.
The condition is inherited, although the pattern of inheritance can vary between different forms of hypophosphatasia.
Q8. Can Hypophosphatasia be cured?
There is currently no cure for the underlying genetic cause of hypophosphatasia. However, enzyme replacement therapy can help improve bone mineralisation and other manifestations in eligible patients.
Treatment and monitoring are tailored to the person's age, severity, symptoms, and complications. Regular follow-up with appropriate specialists is important for long-term care.






